scroll to top
0

EBSCO Auth Banner

Let's find your institution. Click here.

Advanced Search Results For "KAM, KEN"

1 - 10 of 112 results for
 "KAM, KEN"
Results per page:

68Ga-PSMA PET/CT versus CT and bone scan for investigation of PSA failure post radical prostatectomy

Publication Type: Academic Journal

Source(s): Asian Journal of Urology, Vol 8, Iss 2, Pp 170-175 (2021)

Abstract: Objective: To evaluate the use of Gallium-68 prostate-specific membrane antigen positron emission tomography/computed tomography (68Ga-PSMA PET/CT), compared with conventional CT abdomen/pelvis (CTAP) and whole body single photon emission CT bone scan ...

View details

PEMT, Δ6 desaturase, and palmitoyldocosahexaenoyl phosphatidylcholine are increased in rats during pregnancy[S]

Publication Type: Academic Journal

Source(s): Journal of Lipid Research, Vol 59, Iss 1, Pp 123-136 (2018)

Abstract: DHA is important for fetal neurodevelopment. During pregnancy, maternal plasma DHA increases, but the mechanism is not fully understood. Using rats fed a fixed-formula diet (DHA as 0.07% total energy), plasma and liver were collected for fatty acid pro...

View details

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Publication Type: Periodical

Source(s): The Lancet; February 2022, Vol. 399 Issue: 10325 p665-676, 12p

Abstract: Casirivimab and imdevimab are non-competing monoclonal antibodies that bind to two different sites on the receptor binding domain of the SARS-CoV-2 spike glycoprotein, blocking viral entry into host cells. We aimed to evaluate the efficacy and safety o...

View details

Variants at the APOE/C1/C2/C4 Locus Modulate Cholesterol Efflux Capacity Independently of High‐Density Lipoprotein Cholesterol

Publication Type: Academic Journal

Source(s): Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 7, Iss 16 (2018)

Abstract: Background Macrophage cholesterol efflux to high‐density lipoproteins (HDLs) is the first step of reverse cholesterol transport. The cholesterol efflux capacity (CEC) of HDL particles is a protective risk factor for coronary artery disease independent ...

View details

Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Publication Type: Periodical

Source(s): The Lancet; January 2022, Vol. 399 Issue: 10320 p143-151, 9p

Abstract: Aspirin has been proposed as a treatment for COVID-19 on the basis of its anti-thrombotic properties. We aimed to evaluate the efficacy and safety of aspirin in patients admitted to hospital with COVID-19.

View details

Presence of proNGF-Sortilin Signaling Complex in Nigral Dopamine Neurons and Its Variation in Relation to Aging, Lactacystin and 6-OHDA Insults

Publication Type: Academic Journal

Source(s): International Journal of Molecular Sciences, Vol 14, Iss 7, Pp 14085-14104 (2013)

Abstract: Growing evidence has shown that proNGF-p75NTR-sortilin signaling might be a crucial factor in neurodegeneration, but it remains unclear if it may function in nigral neurons under aging and disease. The purpose of this study is to examine and quantify p...

View details

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial

Publication Type: Periodical

Source(s): The Lancet; May-June 2021, Vol. 397 Issue: 10289 p2049-2059, 11p

Abstract: Many patients with COVID-19 have been treated with plasma containing anti-SARS-CoV-2 antibodies. We aimed to evaluate the safety and efficacy of convalescent plasma therapy in patients admitted to hospital with COVID-19.

View details

Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Publication Type: Periodical

Source(s): The Lancet; May 2021, Vol. 397 Issue: 10285 p1637-1645, 9p

Abstract: In this study, we aimed to evaluate the effects of tocilizumab in adult patients admitted to hospital with COVID-19 with both hypoxia and systemic inflammation.

View details
sponsored